PCV20 (pneumococcal conjugate vaccine)
GPTKB entity
Statements (40)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:approvalYear |
2021
|
| gptkbp:approvedBy |
gptkb:FDA
adults children |
| gptkbp:ATCCode |
J07AL06
|
| gptkbp:brand |
Prevnar 20
|
| gptkbp:broadcastOn |
single dose
|
| gptkbp:containsAdjuvant |
aluminum phosphate
|
| gptkbp:containsAntigen |
capsular polysaccharide
|
| gptkbp:containsSerotype |
gptkb:18C
gptkb:19F gptkb:23F 1 3 4 5 8 11A 6B 9V 6A 19A 7F 10A 15B 12F 22F 33F |
| https://www.w3.org/2000/01/rdf-schema#label |
PCV20 (pneumococcal conjugate vaccine)
|
| gptkbp:indication |
prevention of invasive pneumococcal disease
prevention of pneumonia |
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:numberOfSerotypesCovered |
20
|
| gptkbp:predecessor |
gptkb:PCV13
|
| gptkbp:protectedBy |
gptkb:Streptococcus_pneumoniae
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:WHOPrequalified |
no
|
| gptkbp:bfsParent |
gptkb:Vaxcyte
|
| gptkbp:bfsLayer |
7
|